← Leaderboards
Gaya K. Amarasinghe
Washington University
$21,435,025
Attributed
$28,678,949
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.6M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,132,853 · 16
By mechanism
P01$32,126,877 · 5
R01$16,891,655 · 6
R41$1,160,409 · 2
R42$977,449 · 1
R56$533,763 · 1
R21$442,700 · 1
Top collaborators
- Amy L Hartman8 shared
- Christopher F Basler7 shared
- Nevan J Krogan6 shared
- Gai Liu3 shared
- Brian S J Blagg2 shared
- Frederick Wayne Holtsberg2 shared
Most similar at Washington University
Same institution · by research overlap
- Daved H Fremont$19,011,013
- Christopher F Basler$44,557,002
- Sean P. J. Whelan$36,954,740
- Carolyn Sargent$78,463
- Stephanie Larchanche$58,274
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralProteinsDisease OutbreaksVirusBiochemicalVirus ReplicationInnovationCellsVirus DiseasesIntegration Host FactorsPathogenMolecularEbola VirusComplexInfectionInsightGlobal HealthIn VitroResearch PersonnelProteomicsRna VirusesViral RnaBindingBase
Grant awards (61)
Molecular Mechanisms of Filoviral-host Interactions$3,374,001
P01 · FY2025 · AI · contact PI
Biochemical and structural mechanisms at the filoviral-host interface$1,099,141
P01 · FY2025 · AI · contact PI
Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral$977,449
R42 · FY2025 · AI
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses$767,375
R01 · FY2025 · AI · contact PI
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis$731,052
R01 · FY2025 · AI · contact PI
Administrative Core$209,668
P01 · FY2025 · AI · contact PI
Molecular Mechanisms of Filoviral-host Interactions$3,374,001
P01 · FY2024 · AI · contact PI
Biochemical and structural mechanisms at the filoviral-host interface$1,189,295
P01 · FY2024 · AI · contact PI
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses$767,375
R01 · FY2024 · AI · contact PI
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis$735,323
R01 · FY2024 · AI · contact PI
Administrative Core$270,082
P01 · FY2024 · AI · contact PI
HSP90 paralog selective small molecules as anti-old-world alpha-viral therapeutic leads.$194,975
R21 · FY2024 · AI · contact PI
Molecular Mechanisms of Filoviral-host Interactions$3,354,992
P01 · FY2023 · AI · contact PI
Biochemical and structural mechanisms at the filoviral-host interface$1,112,463
P01 · FY2023 · AI · contact PI
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses$783,556
R01 · FY2023 · AI · contact PI
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection$762,140
R01 · FY2023 · AI · contact PI
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis$739,505
R01 · FY2023 · AI · contact PI
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2$638,713
R01 · FY2023 · AI · contact PI
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2$388,750
R01 · FY2023 · AI · contact PI
Administrative Core$275,156
P01 · FY2023 · AI · contact PI
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy$272,089
R41 · FY2023 · AI
HSP90 paralog selective small molecules as anti-old-world alpha-viral therapeutic leads.$247,725
R21 · FY2023 · AI · contact PI
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection$61,201
R01 · FY2023 · AI · contact PI
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection$774,291
R01 · FY2022 · AI · contact PI
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis$742,007
R01 · FY2022 · AI · contact PI
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2$649,870
R01 · FY2022 · AI · contact PI
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2$393,750
R01 · FY2022 · AI · contact PI
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy$296,536
R41 · FY2022 · AI
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection$786,333
R01 · FY2021 · AI · contact PI
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis$756,494
R01 · FY2021 · AI · contact PI
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2$667,277
R01 · FY2021 · AI · contact PI
Whispering Gallery Mode Devices for the Rapid Detection of Pan-Filoviruses$291,845
R41 · FY2021 · AI
Structural and Functional Characterization of the Ebola Virus Replication Complex$2,554,916
P01 · FY2020 · AI · contact PI
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection$796,422
R01 · FY2020 · AI · contact PI
Structural Mechanisms of Ebola Virus RNA Synthesis$773,062
P01 · FY2020 · AI · contact PI
Whispering Gallery Mode Devices for the Rapid Detection of Pan-Filoviruses$299,939
R41 · FY2020 · AI
Structural and Functional Studies of Ebola Virus RNA Synthesis$140,854
P01 · FY2020 · AI · contact PI
Structural and Functional Characterization of the Ebola Virus Replication Complex$2,563,154
P01 · FY2019 · AI · contact PI
Novel VP30-host Interactions that Negatively Regulate Ebola Virus Infection$832,743
R01 · FY2019 · AI · contact PI
Structural Mechanisms of Ebola Virus RNA Synthesis$703,476
P01 · FY2019 · AI · contact PI
Structural and Functional Studies of Ebola Virus RNA Synthesis$140,126
P01 · FY2019 · AI · contact PI
Structural and Functional Characterization of the Ebola Virus Replication Complex$2,613,671
P01 · FY2018 · AI · contact PI
Multi-platform High Throughput Screens for Filoviral Replication Inhibitors$704,845
R01 · FY2018 · AI · contact PI
Structural Mechanisms of Ebola Virus RNA Synthesis$654,142
P01 · FY2018 · AI · contact PI
Structural and Functional Studies of Ebola Virus RNA Synthesis$169,017
P01 · FY2018 · AI · contact PI
Structural and Functional Characterization of the Ebola Virus Replication Complex$2,742,882
P01 · FY2017 · AI · contact PI
Multi-platform High Throughput Screens for Filoviral Replication Inhibitors$808,703
R01 · FY2017 · AI · contact PI
Structural Mechanisms of Ebola Virus RNA Synthesis$750,810
P01 · FY2017 · AI · contact PI
DEVELOPMENT, VALIDATION, AND OPTIMIZATION OF HTS SCREENS TARGETING NIPAH AND HENDRA VIRUS RNA SYNTHESIS$533,763
R56 · FY2017 · AI · contact PI
Structural and Functional Studies of Ebola Virus RNA Synthesis$209,451
P01 · FY2017 · AI · contact PI
Structural and Functional Characterization of the Ebola Virus Replication Complex$2,876,287
P01 · FY2016 · AI · contact PI
Structural Mechanisms of Ebola Virus RNA Synthesis$793,286
P01 · FY2016 · AI · contact PI
Multi-platform High Throughput Screens for Filoviral Replication Inhibitors$611,960
R01 · FY2016 · AI · contact PI
Structural and Functional Studies of Ebola Virus RNA Synthesis$182,944
P01 · FY2016 · AI · contact PI
Multi-platform High Throughput Screens for Filoviral Replication Inhibitors$23,064
R01 · FY2016 · AI · contact PI
Structural studies of Ebola VP35 mediated immune evasion mechanisms$350,092
R01 · FY2013 · AI · contact PI
Structural studies of Ebola VP35 mediated immune evasion mechanisms$372,438
R01 · FY2012 · AI · contact PI
Structural studies of Ebola VP35 mediated immune evasion mechanisms$243,200
R01 · FY2011 · AI · contact PI
Structural studies of Ebola VP35 mediated immune evasion mechanisms$137,516
R01 · FY2011 · AI · contact PI
Structural studies of Ebola VP35 mediated immune evasion mechanisms$523,715
R01 · FY2010 · AI · contact PI
Structural studies of Ebola VP35 mediated immune evasion mechanisms$341,945
R01 · FY2009 · AI · contact PI